Replies to post #11161 on Momenta Pharmaceuticals, Inc. (MNTA)

[pollyvonwog]

Sub 15 seems for certain and certainly 10-12 range is possible. It may put them close to neutral cash flow, although going forward there cash burn is even higher now, so I tend to think they're still be cash flow negative. I do expect a significantly higher cash flow from copax than enox if there are multiple players, however.

As you know, my bet is that MNTA gets sole approval though and for a significant amount of time. :)